Deloitte ranked #1 worldwide, based on revenue, in Life Sciences Consulting by Kennedy
New York, 13 February 2013 – Deloitte Touche Tohmatsu Limited (DTTL) is pleased to announce that Deloitte has been ranked number one in Life Sciences by Kennedy based on revenue, in their report Consulting to the Life Sciences Sector, 2012.
The report is the first in the series and covers the fastest-growing healthcare sector, life sciences, with analysis aligned to consulting needs across the four subsectors: pharmaceutical, biotechnology, medical device, and drug distribution.
According to the report, Deloitte’s post-transaction services, regulatory and risk expertise and commercial operating models are strengths. Kennedy notes that “Deloitte provides one of the widest ranges of capability in the industry and the relationship models to support large program initiatives. The breadth of these capabilities and the organizational ability to integrate these skills together allow Deloitte to focus on a variety of strategic issues such as pricing and profitability, strategic commercial models, and partnering models for R&D.”
“Deloitte is honored that Kennedy has acknowledged the capabilities of our member firms around the world in serving clients in the life sciences and health care industry,” says Pete Mooney, Global Life Sciences and Health Care (LSHC) industry group leader, DTTL. “Kennedy’s recognition speaks to the breadth and depth of Deloitte’s capabilities, our strong global footprint, and our ability to team across borders and service areas. These accomplishments are a significant source of pride for our industry group.”